Mass spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: Comparison to IHC and FISH

BACKGROUND: Trastuzumab showed survival benefit for Her2-positive gastroesophageal cancers (GEC). Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) currently determine eligibility for trastuzumab-based therapy. However, these low-throughput assays often produce discordant or e...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Gastric Cancer
Päätekijät: Catenacci, Daniel V.T., Liao, Wei-Li, Zhao, Lei, Whitcomb, Emma, Henderson, Les, O’Day, Emily, Xu, Peng, Thyparambil, Sheeno, Krizman, David, Bengali, Kathleen, Uzzell, Jamar, Darfler, Marlene, Cecchi, Fabiola, Blackler, Adele, Bang, Yung-Jue, Hart, John, Xiao, Shu-Yuan, Lee, Sang Mee, Burrows, Jon, Hembrough, Todd
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4871781/
https://ncbi.nlm.nih.gov/pubmed/26581548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10120-015-0566-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia